For some years, an increasing spread of new viruses and other pathogens has been observed. The diseases caused by these pathogenic agents are referred to as “emerging diseases”. This term refers to infectious diseases that either occur for the first time in a population or have increased rapidly in incidence and regional distribution.
Emerging diseases pose a growing challenge for global health. Some influencing factors such as climate change, advancing urbanisation and increasing international mobility facilitate their spread. Besides known pathogens such as dengue, chikungunya and Zika virus, there are other pathogens that had been infrequent until now, which are becoming more and more important as they pose a significant risk for people.
Early identification and continuous monitoring of these pathogens are crucial in order to develop effective strategies to prevent outbreaks.
| Technology | Parameter | Substrate | Species | Calibration | Ig Class | Format | Order No. |
|---|---|---|---|---|---|---|---|
| IIFT |
Bornavirus (BoDV) |
infected and uninfected cells (2 BIOCHIPs per field) |
EU 14 | IgG IgG |
10 x 05 10 x 10 |
FI 2620-1005 G* FI 2620-1010 G* |
|
| IIFT |
Arbovirus Mosaic Australia 2 Murray Valley encephalitis virus (MVEV) Ross River virus (RRV) Barmah forest virus (BFV) |
4 BIOCHIPs per field: infected cells infected cells infected cells non-infected cells |
EU 14 EU 14 EU 14 EU 14 |
IgG IgM |
10 x 05 10 x 05 |
FI 2666-1005-2 G* FI 2666-1005-2 M* |
|
| IIFT |
Crimean Congo fever virus Mosaic 2 CCHFV-GPC CCHFV-N |
3 BIOCHIPs per field: transfected cells transfected cells control transfection |
EU 90 EU 90 EU 90 |
IgG EB IgM EB IgG EB IgM EB IgG EB IgM EB |
10 x 05 10 x 05 10 x 10 10 x 10 20 x 10 20 x 10 |
FI 279a-1005-2 G* FI 279a-1005-2 M* FI 279a-1010-2 G* FI 279a-1010-2 M* FI 279a-2010-2 G* FI 279a-2010-2 M* |
|
| IIFT | Rift Valley fever virus (RVFV) |
infected and non- infected cells (2 BIOCHIPs per field) |
EU 14 | IgG IgM IgG IgM |
10 x 05 10 x 05 10 x 10 10 x 10 |
FI 280a-1005 G* FI 280a-1005 M* FI 280a-1010 G* FI 280a-1010 M* |
|
| IIFT |
Venezuelan equine encephalitis virus (VEEV) |
infected and non- infected cells (2 BIOCHIPs per field) |
EU 14 | IgG |
10 x 10 |
FI 290a-1010 G* | |
| IIFT | Sindbis virus (SINV) |
infected and non- infected cells (2 BIOCHIPs per field) |
EU 14 | IgM IgG IgM |
10 x 05 10 x 10 10 x 10 |
FI 291a-1005 M* FI 291a-1010 G* FI 291a-1010 M* |
|
|
* For research use only, not for in vitro diagnostic use in the sense of EU directive 98/79/EC. 1 Product manufactured by third party. Please contact your local Euroimmun representative for more information. | |||||||